Obesity Drugs are Problematic

Tuesday, November 20, 2007 - Byron J. Richards, CCN

Obesity drugs are big business, pulling in 1.2 billion in sales last year.  The British Medical Journal just published a review of the three main weight loss drugs and found that Orlistat increased rates of gastrointestinal side effects and slightly lowered concentrations of HDL cholesterol (good cholesterol), Sibutramine lowered concentrations of HDL, raised blood pressure, and increased pulse rate, and Rimonabant increased the risk of depression, anxiety, and mood disorders.

There is no quick-fix drug for obesity.  Mastering Leptin is the key, which requires consistency over a period of time.  Weight loss drugs are not worth the risk

Related Entries:

###

Other Weight Loss News

View complete Weight Loss News Archives

My cart is empty.   View Cart | Login

• All Health News
• Health News
• Health Tips
• Weight Loss News
• Weight Loss Tips
• Health Freedom News

• The Five Rules of The Leptin Diet®
• What is Leptin?
• Lack of Sleep, Stress, Adrenals, and Obesity
• Thyroid, Food Addiction, and the Metabolically Unfit Fat Cell
• Zinc, Alcohol Damage, and Thyroid Function